BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 30232390)

  • 1. Distinct profile and prognostic impact of body composition changes in idiopathic pulmonary fibrosis and idiopathic pleuroparenchymal fibroelastosis.
    Suzuki Y; Yoshimura K; Enomoto Y; Yasui H; Hozumi H; Karayama M; Furuhashi K; Enomoto N; Fujisawa T; Nakamura Y; Inui N; Suda T
    Sci Rep; 2018 Sep; 8(1):14074. PubMed ID: 30232390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative computed tomography measures of skeletal muscle mass in patients with idiopathic pulmonary fibrosis according to a multidisciplinary discussion diagnosis: A retrospective nationwide study in Japan.
    Awano N; Inomata M; Kuse N; Tone M; Yoshimura H; Jo T; Takada K; Sugimoto C; Tanaka T; Sumikawa H; Suzuki Y; Fujisawa T; Suda T; Izumo T
    Respir Investig; 2020 Mar; 58(2):91-101. PubMed ID: 31882370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative analysis of lung elastic fibers in idiopathic pleuroparenchymal fibroelastosis (IPPFE): comparison of clinical, radiological, and pathological findings with those of idiopathic pulmonary fibrosis (IPF).
    Enomoto N; Kusagaya H; Oyama Y; Kono M; Kaida Y; Kuroishi S; Hashimoto D; Fujisawa T; Yokomura K; Inui N; Nakamura Y; Suda T
    BMC Pulm Med; 2014 May; 14():91. PubMed ID: 24886550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of lower-lobe interstitial lung disease on high-resolution computed tomography in patients with idiopathic pleuroparenchymal fibroelastosis.
    Kono M; Fujita Y; Takeda K; Miyashita K; Tsutsumi A; Kobayashi T; Miki Y; Hashimoto D; Enomoto N; Nakamura Y; Suda T; Nakamura H
    Respir Med; 2019; 154():122-126. PubMed ID: 31238182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Body composition changes successfully classify prognosis in patients with mycobacterium avium complex lung disease.
    Akahori D; Suzuki Y; Yokomura K; Shirai M; Yasui H; Hozumi H; Karayama M; Furuhashi K; Enomoto N; Fujisawa T; Nakamura Y; Inui N; Hayakawa H; Suda T
    J Infect; 2019 Oct; 79(4):341-348. PubMed ID: 31376456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cause of mortality and sarcopenia in patients with idiopathic pulmonary fibrosis receiving antifibrotic therapy.
    Suzuki Y; Aono Y; Kono M; Hasegawa H; Yokomura K; Naoi H; Hozumi H; Karayama M; Furuhashi K; Enomoto N; Fujisawa T; Nakamura Y; Inui N; Nakamura H; Suda T
    Respirology; 2021 Feb; 26(2):171-179. PubMed ID: 32969124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease course and prognosis of pleuroparenchymal fibroelastosis compared with idiopathic pulmonary fibrosis.
    Suzuki Y; Fujisawa T; Sumikawa H; Tanaka T; Sugimoto C; Kono M; Hozumi H; Karayama M; Furuhashi K; Enomoto N; Nakamura Y; Inui N; Suda T
    Respir Med; 2020 Sep; 171():106078. PubMed ID: 32917352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poorer Prognosis of Idiopathic Pleuroparenchymal Fibroelastosis Compared with Idiopathic Pulmonary Fibrosis in Advanced Stage.
    Shioya M; Otsuka M; Yamada G; Umeda Y; Ikeda K; Nishikiori H; Kuronuma K; Chiba H; Takahashi H
    Can Respir J; 2018; 2018():6043053. PubMed ID: 30186537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic impact of the cross-sectional area of the erector spinae muscle in patients with pleuroparenchymal fibroelastosis.
    Kitahara S; Abe M; Kono C; Sakuma N; Ishii D; Kawasaki T; Ikari J; Suzuki T
    Sci Rep; 2023 Oct; 13(1):17289. PubMed ID: 37828047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Limited efficacy of nintedanib for idiopathic pleuroparenchymal fibroelastosis.
    Kinoshita Y; Miyamura T; Ikeda T; Ueda Y; Yoshida Y; Kushima H; Ishii H
    Respir Investig; 2022 Jul; 60(4):562-569. PubMed ID: 35398003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative Assessment of Erector Spinae Muscles in Patients with Chronic Obstructive Pulmonary Disease. Novel Chest Computed Tomography-derived Index for Prognosis.
    Tanimura K; Sato S; Fuseya Y; Hasegawa K; Uemasu K; Sato A; Oguma T; Hirai T; Mishima M; Muro S
    Ann Am Thorac Soc; 2016 Mar; 13(3):334-41. PubMed ID: 26700501
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Criteria for the diagnosis of idiopathic pleuroparenchymal fibroelastosis: A proposal.
    Watanabe K; Ishii H; Kiyomi F; Terasaki Y; Hebisawa A; Kawabata Y; Johkoh T; Sakai F; Kondoh Y; Inoue Y; Azuma A; Suda T; Ogura T; Inase N; Homma S;
    Respir Investig; 2019 Jul; 57(4):312-320. PubMed ID: 30981683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Body Mass Index and arterial blood oxygenation as prognostic factors in patients with idiopathic pleuroparenchymal fibroelastosis.
    Hayashi H; Nei T; Abe S; Saito Y; Kokuho N; Atsumi K; Fujita K; Saito T; Tanaka T; Gemma A; Azuma A
    Sarcoidosis Vasc Diffuse Lung Dis; 2017; 34(1):35-40. PubMed ID: 32476820
    [No Abstract]   [Full Text] [Related]  

  • 14. Early decrease in erector spinae muscle area and future risk of mortality in idiopathic pulmonary fibrosis.
    Nakano A; Ohkubo H; Taniguchi H; Kondoh Y; Matsuda T; Yagi M; Furukawa T; Kanemitsu Y; Niimi A
    Sci Rep; 2020 Feb; 10(1):2312. PubMed ID: 32047177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Remodeling of the pulmonary artery in idiopathic pleuroparenchymal fibroelastosis.
    Kinoshita Y; Ishii H; Kushima H; Johkoh T; Yabuuchi H; Fujita M; Nabeshima K; Watanabe K
    Sci Rep; 2020 Jan; 10(1):306. PubMed ID: 31941942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of lung transplantation for idiopathic pleuroparenchymal fibroelastosis.
    Shiiya H; Nakajima J; Date H; Chen-Yoshikawa TF; Tanizawa K; Handa T; Oto T; Otani S; Shiotani T; Okada Y; Matsuda Y; Shiraishi T; Moroga T; Minami M; Funaki S; Chida M; Yoshino I; Hatachi G; Uemura Y; Sato M
    Surg Today; 2021 Aug; 51(8):1276-1284. PubMed ID: 33576927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thoracic skeletal muscle quantification: low muscle mass is related with worse prognosis in idiopathic pulmonary fibrosis patients.
    Moon SW; Choi JS; Lee SH; Jung KS; Jung JY; Kang YA; Park MS; Kim YS; Chang J; Kim SY
    Respir Res; 2019 Feb; 20(1):35. PubMed ID: 30767787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skeletal muscle atrophy and short-term mortality in patients with acute exacerbation of idiopathic pulmonary fibrosis: an observational cohort study.
    Ito Y; Anan K; Awano N; Kataoka Y; Johkoh T; Fujimoto K; Ichikado K; Tobino K; Tachikawa R; Ito H; Nakamura T; Kishaba T; Yamamoto Y; Inomata M; Izumo T
    Respir Investig; 2023 Jul; 61(4):371-378. PubMed ID: 37079942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical profile of unclassifiable interstitial lung disease: Comparison with chronic fibrosing idiopathic interstitial pneumonias.
    Traila D; Oancea C; Tudorache E; Mladinescu OF; Timar B; Tudorache V
    J Int Med Res; 2018 Jan; 46(1):448-456. PubMed ID: 28758849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low Daily Step Count Associated with Small Erector Spinae Muscle Area and Sarcopenia in Idiopathic Pulmonary Fibrosis.
    Ohkubo H; Fujita K; Ito K; Nakano A; Horiuchi M; Mori Y; Fukumitsu K; Fukuda S; Kanemitsu Y; Uemura T; Tajiri T; Ito Y; Ozawa Y; Murase T; Niimi A
    Intern Med; 2024 May; 63(10):1345-1352. PubMed ID: 37839878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.